Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CardioGen Sciences

2014 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Provider of healthcare services. The company develops gene therapy provisions for orphan inherited arrhythmogenic diseases.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • Palo Alto, CA
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CardioGen Sciences’s full profile, request a free trial.

CardioGen Sciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Sep-2015 00000 Completed Startup
1. Seed Round 01-Dec-2014 00000 00000 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

CardioGen Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

CardioGen Sciences Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Asset Management Ventures Venture Capital Minority 000 0000 000000 0

CardioGen Sciences Executive Team (1)

Name Title Board
Seat
Contact
Info
Louis Lange MD Founder

CardioGen Sciences Board Members (2)

Name Representing Role Since Contact
Info
Edmund Ruffin CardioGen Sciences Board Member 000 0000
Silvia Priori CardioGen Sciences Board Member 000 0000